BioCentury
ARTICLE | Financial News

Sepracor raises $22 million

July 10, 2001 7:00 AM UTC

SEPR, which is developing therapeutics for respiratory, urological and CNS disorders, raised $22 million through the sale of 2 million shares of BioSphere Medical (BSMD) that were owned by SEPR. SEPR ...